Authorship and review
Named authors and reviewers are used where their verified role and contribution support the subject. “Medically reviewed” is not used unless a suitably qualified reviewer actually performs that review.
Legal and responsibility
Legal information, accountability and responsible business.
This area explains how NovaPharm governs website use, personal data, accessibility, ethical sourcing and its developing environmental responsibilities.
Privacy notice
Personal data, lawful bases, recipients, retention criteria and rights.
Read documentCookie and storage notice
Necessary cookies, browser storage and consent preferences.
Read documentWebsite terms
Corporate website and secure-portal use.
Read documentAccessibility
WCAG 2.2 AA target, testing and support.
Read documentModern slavery and human rights
Voluntary ethical-sourcing and supply-chain policy.
Read documentEnvironment and carbon
Voluntary measurement and responsible-procurement statement.
Read documentEditorial governance
Standards for pharmaceutical and corporate content.
NovaPharm publishes corporate B2B information, operating frameworks and analysis under evidence, authorship and correction controls.
Sources and updates
Primary sources such as legislation, competent authorities, ICH, official filings and peer-reviewed literature are preferred. Material updates change the displayed modified date; cosmetic builds do not create false freshness.
Corrections and conflicts
Material factual errors are corrected transparently. Commercial relationships, future intentions and professional interpretation must not be presented as independent regulatory approval or current product availability.
Scope limitation
The website does not provide patient-level diagnosis, treatment or medicine-use advice. Questions about a published fact or correction may be submitted through the corporate contact route.